Clinical Trials Directory

Trials / Completed

CompletedNCT04300231

Thoracic Epidural Analgesia Versus Rectus Sheath Block Versus Surgeon Infiltration With Liposomal Bupivacaine or Standard Bupivacaine for Post-Operative Pain Control After Cystectomy

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
160 (actual)
Sponsor
Indiana University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the difference between four different pain control methods in patients who will be having a cystectomy surgery (surgical removal of the bladder).

Detailed description

The purpose of this study is to compare the difference between four different pain control methods in patients who will be having a cystectomy surgery (surgical removal of the bladder). By collecting this data, we aim to show improved postoperative pain scores, decreased opioid needs, and decreased opioid side effects (feeling sick to your stomach, feeling drowsy/sleepy, blockage/lack of movement in the intestines, inability to completely empty the bladder, unusually slow or shallow breathing). The specific aim of this study is to compare the difference between the pain control methods in achieving the following: 1. Decreased opioid requirements 2. Improved postoperative VAS pain scores 3. Decreased opioid side effects (Nausea, sedation, ileus, respiratory depression) 4. Decreased hospital length of stay (LOS)

Conditions

Interventions

TypeNameDescription
DRUGepidural bupivacaine 0.05%Mix of epidural bupivacaine 0.05% and hydromorphone 0.05mg/ml will be given using PCEA.
DRUGLiposomal bupivacaine20 ml
DRUGbupivacaine 0.125%40 mL
DRUGbupivacaine 0.5%60 mL
DRUG/hydromorphone 0.05mg/mlMix of epidural bupivacaine 0.05% and hydromorphone 0.05mg/ml will be given using PCEA.
DRUGinjectable saline40 mL

Timeline

Start date
2019-10-22
Primary completion
2021-12-23
Completion
2021-12-24
First posted
2020-03-09
Last updated
2025-02-10
Results posted
2025-02-10

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04300231. Inclusion in this directory is not an endorsement.